• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INJECTOR LUER LOCK N35; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INJECTOR LUER LOCK N35; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Catalog Number 515003
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2024
Type of Reportable Event Malfunction
Event or Problem Description
User was using injector luer lock (n35) for reconstitution of chemo drug and realized leaking from the luer lock.
 
Additional Manufacturer Narrative
Initial mdr submission.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Additional Manufacturer Narrative
(b)(4) follow up mdr for device evaluation: one video was provided to our quality team for investigation.Through visual inspection, liquid is observed to be leaking from the injector.It was noted, when the plunger was pressed on the syringe, the injector was not properly engaged with a mating component.As a result, this creates pressure within the device, causing damage to the internal components and eventually leading to the leakage as observed within the video.A device history review was performed for reported lot 2304004, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this issue.Retained samples of lot 2304004 were used for additional evaluation.Dimensional testing was performed on the injectors , including the luer thread, verifying all critical dimensions are within specification.Leakage and pressure testing is performed for all lots during manufacturing to ensure the quality of the membrane.Results were reviewed for the reported lot and verified to be within specification.Based on our quality team's investigation and video evaluation, this incident likely occurred as a result of improperly engaging the device as the injector must be connected to a mating component when pressing on the syringe plunger to properly open the fluid path and allow liquid to flow.It is important to follow the instructions for use when using phaseal devices to ensure the product functions properly.Complaints received for this device and reported condition will be monitored by our quality team for signs of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INJECTOR LUER LOCK N35
Common Device Name
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix 22520
SP   22520
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19310552
Report Number3003152976-2024-00289
Device Sequence Number3076704
Product Code ONB
UDI-Device Identifier00382905150036
UDI-Public(01)00382905150036
Combination Product (Y/N)N
Initial Reporter CountryMY
PMA/510(K) Number
K140591
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative,Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Catalogue Number515003
Device Lot Number2304004
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/10/2024
Supplement Date Received by Manufacturer08/26/2024
Initial Report FDA Received Date05/14/2024
Supplement Report FDA Received Date08/27/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/02/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-